Skip to main content

Table 2 Laboratory values and radiographic findings at the admission of COVID-19 patients

From: Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China

 

Normal range

Total (n = 107)

Survivors (n = 88)

Non-survivors (n = 19)

P value

White blood cell count, × 109/L

3.5–9.5

4.6 (3.7–6.1)

4.4 (3.4–5.8)

6.7 (4.6–10.3)

0.004*

Neutrophil count, × 109/L

1.8–6.3

3.1 (2.1–4.7)

2.8 (2.0–3.9)

5.4 (3.2–8.5)

< 0.001*

Lymphocyte count, × 109/L

1.1–3.2

0.9 (0.7–1.2)

0.9 (0.7–1.3)

0.8 (0.5–1.1)

0.121

Platelet count, × 109/L

125–350

175 (129–200)

178 (139–207)

122 (83–178)

0.006*

Prothrombin time, s

9.4–12.5

12.8 (11.9–13.5)

12.9 (12.0–13.5)

12.6 (11.9–13.5)

0.813

Activated partial thromboplastin time, s

25.1–36.5

31.7 (29.4–33.9)

31.7 (29.5–33.5)

32.7 (27.5–37.0)

0.850

D-dimer, mg/L

0–500

203 (121–358)

191 (108–327)

439 (202–1991)

0.003*

Creatine kinase, U/L

< 171

90 (54–138)

86 (53–121)

142 (87–325)

0.022*

Creatine kinase-MB, U/L

< 25

14 (10–18)

13 (9–16)

18 (13–44)

0.008*

Lactate dehydrogenase, U/L

125–243

236 (176–369)

227 (171–329)

456 (254–588)

0.010*

Alanine aminotransferase, U/L

9–50

23 (16–39)

22 (15–34)

47 (22–66)

0.002*

Aspartate aminotransferase, U/L

15–40

31 (24–47)

29 (23–41)

67 (38–90)

< 0.001*

Total bilirubin, mmol/L

5–21

9.8 (8.4–14.1)

9.5 (8.4–12.9)

11.3 (9.4–20.7)

0.069

Blood urea nitrogen, mmol/L

2.8–7.6

4.2 (3.2–5.6)

3.9 (3.0–4.7)

6.1 (4.9–10.5)

< 0.001*

Creatinine, μmol/L

64–104

71 (60–86)

68 (58–83)

87 (71–130)

< 0.001*

Hypersensitive troponin I, > 26.2 pg/mL, no. (%)

< 26.2

6 (5.6)

1 (1.1)

5 (26.3)

0.001*

Multi-lobar involvement on initial radiographs, no. (%)

NA

90 (84.1)

73 (83.0)

17 (89.5)

0.731

Bilateral involvement on radiographs during hospitalization, no. (%)

NA

105 (98.1)

86 (97.7)

19 (100.0)

1.000

  1. Data are median (IQR) or n (%). P values indicate differences between survivors and non-survivors. P < 0.05 was considered significant. Laboratory values and radiographic findings were collected at admission except that the bilateral involvement on radiographs was collected during hospitalization
  2. MB muscle and brain type, NA not available
Back to article page

Critical Care

ISSN: 1364-8535